Jump to content
RemedySpot.com

19 Links to NEW HCV Abstracts from Journal of Viral Hepatitis

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 11

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

The latest issue of Journal of Viral Hepatitis is available on Wiley Online

Library

Volume 18, Issue 4 Page 229 - e166

REVIEW ARTICLE

Hepatitis C virus infection during pregnancy and the newborn period – are they

opportunities for treatment? (pages 229–236)

M. Arshad, S. S. El-Kamary and R. Jhaveri

Article first published online: 7 JAN 2011 | DOI:

10.1111/j.1365-2893.2010.01413.x

ORIGINAL ARTICLES

Total and cause-specific mortality rates in a prospective study of

community-acquired hepatitis C virus infection in northern Norway (pages

237–244)

M. G. Kristiansen, M. -L. Løchen, T. J. Gutteberg, L. Mortensen, B. O. sen

and J. Florholmen

Article first published online: 8 MAR 2010 | DOI:

10.1111/j.1365-2893.2010.01290.x

Ribavirin plasma concentration is a predictor of sustained virological response

in patients treated for chronic hepatitis C virus genotype 2/3 infection (pages

245–251)

C. Pedersen, Å. Alsiö, M. Lagging, N. Langeland, M. Frkkil, M. Rauning Buhl, K.

Mørch, J. Westin, P. Sangfelt, G. Norkrans and P. Brehm Christensen, for the

NORDynamicIC Study Group

Article first published online: 1 APR 2010 | DOI:

10.1111/j.1365-2893.2010.01303.x

Quality of life in patients with various liver diseases (pages 252–261)

H. L. Tillmann, M. Wiese, Y. Braun, J. Wiegand, S. Tenckhoff, J. Mössner,

M. P. Manns and K. Weissenborn

Article first published online: 8 MAR 2010 | DOI:

10.1111/j.1365-2893.2010.01292.x

Measuring the incidence, prevalence and genetic relatedness of hepatitis C

infections among a community recruited sample of injecting drug users, using

dried blood spots (pages 262–270)

V. D. Hope, M. Hickman, S. L. Ngui, S. , M. Telfer, M. Bizzarri, F. Ncube

and J. V. Parry

Article first published online: 27 APR 2010 | DOI:

10.1111/j.1365-2893.2010.01297.x

Controlled release recombinant human interferon-2b for treating patients with

chronic hepatitis C genotype 1: a phase 2a clinical trial (pages 271–279)

I. Dzyublyk, T. Yegorova, L. Moroz, O. Popovych, I. Zaytsev, V. Miroshnichenko,

A. Kromminga, M. M. Wilkes, E. J. van Hoogdalem and J. E. Humphries

Article first published online: 28 MAR 2010 | DOI:

10.1111/j.1365-2893.2010.01298.x

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and

correlation with response to pegylated-interferon-alpha 2b and ribavirin

combination therapy (pages 280–286)

K. Hayashi, Y. Katano, M. Ishigami, A. Itoh, Y. Hirooka, I. Nakano, F. Urano, K.

Yoshioka, H. Toyoda, T. Kumada and H. Goto

Article first published online: 28 MAR 2010 | DOI:

10.1111/j.1365-2893.2010.01305.x

Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and

ribavirin in HIV/HCV-coinfected patients (pages e52–e60)

E. S. A. Araújo, H. Dahari, A. U. Neumann, N. de a Cavalheiro, C. E. Melo,

E. S. de Melo, T. J. Layden, S. J. Cotler and A. A. Barone

Article first published online: 3 AUG 2010 | DOI:

10.1111/j.1365-2893.2010.01358.x

Uptake of hepatitis C antibody testing in patients with end-stage liver disease

in Glasgow, 1993–2007 (pages e61–e65)

S. A. Mc, S. J. Hutchinson, S. Cameron, S. M. Bird, P. R. Mills, A. McLeod

and D. J. Goldberg

Article first published online: 3 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01377.x

Interleukin-28B polymorphisms are associated with hepatitis C virus clearance

and viral load in a HIV-1-infected cohort (pages e66–e74)

L. N. Clausen, N. Weis, K. Astvad, K. Schønning, M. Fenger, H. Krarup, J. Bukh

and T. Benfield

Article first published online: 12 NOV 2010 | DOI:

10.1111/j.1365-2893.2010.01392.x

Estimating the likelihood of sustained virological response in chronic hepatitis

C therapy (pages e81–e90)

S. Mauss, D. Hueppe, C. , J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber,

A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N.

Dikopoulos and T. Witthoeft

Article first published online: 16 SEP 2010 | DOI:

10.1111/j.1365-2893.2010.01372.x

The association of cryoglobulinaemia with sustained virological response in

patients with chronic hepatitis C (pages e91–e98)

A. G. Vigani, A. Macedo de Oliveira, R. Tozzo, M. H. P. Pavan, E. S. Gonçales,

V. Fais, N. S. Gonçales and F. L. Gonçales

Article first published online: 25 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01385.x

Extended treatment duration for treatment naïve chronic hepatitis C genotype 1

late viral responders: a meta-analysis comparing 48 weeks vs 72 weeks of

pegylated interferon and ribavirin (pages e99–e103)

M. Parikh, A. Singh and G. Sood

Article first published online: 18 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01374.x

Factors associated with specialist assessment and treatment for hepatitis C

virus infection in New South Wales, Australia (pages e104–e116)

J. Grebely, J. , P. Hull, M. Hopwood, Y. Lavis, G. J. Dore and C. Treloar

Article first published online: 14 SEP 2010 | DOI:

10.1111/j.1365-2893.2010.01370.x

Original Articles

Correlation between mutations in the core and NS5A genes of hepatitis C virus

genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and

ribavirin combination therapy (pages e117–e125)

K. Kumthip, C. Pantip, P. Chusri, S. Thongsawat, A. O’Brien, K. E. and N.

Maneekarn

Article first published online: 19 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01379.x

ORIGINAL ARTICLES

The influence of hepatitis C and alcohol on liver-related morbidity and

mortality in Glasgow’s injecting drug user population (pages e126–e133)

S. A. Mc, S. J. Hutchinson, P. R. Mills, S. M. Bird, S. Cameron, J. F.

Dillon and D. J. Goldberg

Article first published online: 22 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01380.x

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial (pages

e134–e143)

A. J. Muir, K. -Q. Hu, S. C. Gordon, K. Koury, N. Boparai, S. Noviello, J. K.

Albrecht, M. S. Sulkowski and J. McCone

Article first published online: 25 NOV 2010 | DOI:

10.1111/j.1365-2893.2010.01402.x

Serum lipids and their associations with viral levels and liver disease severity

in a treatment-naïve chronic hepatitis C type 1-infected cohort (pages

e144–e152)

D. Ramcharran, A. S. Wahed, H. S. Conjeevaram, R. W. , T. Wang, S. H. Belle

and L. J. Yee

Article first published online: 10 NOV 2010 | DOI:

10.1111/j.1365-2893.2010.01394.x

GB virus C infection among young, HIV-negative injection drug users with and

without hepatitis C virus infection (pages e153–e159)

B. Boodram, R. C. Hershow, D. Klinzman and J. T. Stapleton

Article first published online: 3 AUG 2010 | DOI:

10.1111/j.1365-2893.2010.01350.x

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

The latest issue of Journal of Viral Hepatitis is available on Wiley Online

Library

Volume 18, Issue 4 Page 229 - e166

REVIEW ARTICLE

Hepatitis C virus infection during pregnancy and the newborn period – are they

opportunities for treatment? (pages 229–236)

M. Arshad, S. S. El-Kamary and R. Jhaveri

Article first published online: 7 JAN 2011 | DOI:

10.1111/j.1365-2893.2010.01413.x

ORIGINAL ARTICLES

Total and cause-specific mortality rates in a prospective study of

community-acquired hepatitis C virus infection in northern Norway (pages

237–244)

M. G. Kristiansen, M. -L. Løchen, T. J. Gutteberg, L. Mortensen, B. O. sen

and J. Florholmen

Article first published online: 8 MAR 2010 | DOI:

10.1111/j.1365-2893.2010.01290.x

Ribavirin plasma concentration is a predictor of sustained virological response

in patients treated for chronic hepatitis C virus genotype 2/3 infection (pages

245–251)

C. Pedersen, Å. Alsiö, M. Lagging, N. Langeland, M. Frkkil, M. Rauning Buhl, K.

Mørch, J. Westin, P. Sangfelt, G. Norkrans and P. Brehm Christensen, for the

NORDynamicIC Study Group

Article first published online: 1 APR 2010 | DOI:

10.1111/j.1365-2893.2010.01303.x

Quality of life in patients with various liver diseases (pages 252–261)

H. L. Tillmann, M. Wiese, Y. Braun, J. Wiegand, S. Tenckhoff, J. Mössner,

M. P. Manns and K. Weissenborn

Article first published online: 8 MAR 2010 | DOI:

10.1111/j.1365-2893.2010.01292.x

Measuring the incidence, prevalence and genetic relatedness of hepatitis C

infections among a community recruited sample of injecting drug users, using

dried blood spots (pages 262–270)

V. D. Hope, M. Hickman, S. L. Ngui, S. , M. Telfer, M. Bizzarri, F. Ncube

and J. V. Parry

Article first published online: 27 APR 2010 | DOI:

10.1111/j.1365-2893.2010.01297.x

Controlled release recombinant human interferon-2b for treating patients with

chronic hepatitis C genotype 1: a phase 2a clinical trial (pages 271–279)

I. Dzyublyk, T. Yegorova, L. Moroz, O. Popovych, I. Zaytsev, V. Miroshnichenko,

A. Kromminga, M. M. Wilkes, E. J. van Hoogdalem and J. E. Humphries

Article first published online: 28 MAR 2010 | DOI:

10.1111/j.1365-2893.2010.01298.x

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and

correlation with response to pegylated-interferon-alpha 2b and ribavirin

combination therapy (pages 280–286)

K. Hayashi, Y. Katano, M. Ishigami, A. Itoh, Y. Hirooka, I. Nakano, F. Urano, K.

Yoshioka, H. Toyoda, T. Kumada and H. Goto

Article first published online: 28 MAR 2010 | DOI:

10.1111/j.1365-2893.2010.01305.x

Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and

ribavirin in HIV/HCV-coinfected patients (pages e52–e60)

E. S. A. Araújo, H. Dahari, A. U. Neumann, N. de a Cavalheiro, C. E. Melo,

E. S. de Melo, T. J. Layden, S. J. Cotler and A. A. Barone

Article first published online: 3 AUG 2010 | DOI:

10.1111/j.1365-2893.2010.01358.x

Uptake of hepatitis C antibody testing in patients with end-stage liver disease

in Glasgow, 1993–2007 (pages e61–e65)

S. A. Mc, S. J. Hutchinson, S. Cameron, S. M. Bird, P. R. Mills, A. McLeod

and D. J. Goldberg

Article first published online: 3 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01377.x

Interleukin-28B polymorphisms are associated with hepatitis C virus clearance

and viral load in a HIV-1-infected cohort (pages e66–e74)

L. N. Clausen, N. Weis, K. Astvad, K. Schønning, M. Fenger, H. Krarup, J. Bukh

and T. Benfield

Article first published online: 12 NOV 2010 | DOI:

10.1111/j.1365-2893.2010.01392.x

Estimating the likelihood of sustained virological response in chronic hepatitis

C therapy (pages e81–e90)

S. Mauss, D. Hueppe, C. , J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber,

A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N.

Dikopoulos and T. Witthoeft

Article first published online: 16 SEP 2010 | DOI:

10.1111/j.1365-2893.2010.01372.x

The association of cryoglobulinaemia with sustained virological response in

patients with chronic hepatitis C (pages e91–e98)

A. G. Vigani, A. Macedo de Oliveira, R. Tozzo, M. H. P. Pavan, E. S. Gonçales,

V. Fais, N. S. Gonçales and F. L. Gonçales

Article first published online: 25 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01385.x

Extended treatment duration for treatment naïve chronic hepatitis C genotype 1

late viral responders: a meta-analysis comparing 48 weeks vs 72 weeks of

pegylated interferon and ribavirin (pages e99–e103)

M. Parikh, A. Singh and G. Sood

Article first published online: 18 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01374.x

Factors associated with specialist assessment and treatment for hepatitis C

virus infection in New South Wales, Australia (pages e104–e116)

J. Grebely, J. , P. Hull, M. Hopwood, Y. Lavis, G. J. Dore and C. Treloar

Article first published online: 14 SEP 2010 | DOI:

10.1111/j.1365-2893.2010.01370.x

Original Articles

Correlation between mutations in the core and NS5A genes of hepatitis C virus

genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and

ribavirin combination therapy (pages e117–e125)

K. Kumthip, C. Pantip, P. Chusri, S. Thongsawat, A. O’Brien, K. E. and N.

Maneekarn

Article first published online: 19 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01379.x

ORIGINAL ARTICLES

The influence of hepatitis C and alcohol on liver-related morbidity and

mortality in Glasgow’s injecting drug user population (pages e126–e133)

S. A. Mc, S. J. Hutchinson, P. R. Mills, S. M. Bird, S. Cameron, J. F.

Dillon and D. J. Goldberg

Article first published online: 22 OCT 2010 | DOI:

10.1111/j.1365-2893.2010.01380.x

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial (pages

e134–e143)

A. J. Muir, K. -Q. Hu, S. C. Gordon, K. Koury, N. Boparai, S. Noviello, J. K.

Albrecht, M. S. Sulkowski and J. McCone

Article first published online: 25 NOV 2010 | DOI:

10.1111/j.1365-2893.2010.01402.x

Serum lipids and their associations with viral levels and liver disease severity

in a treatment-naïve chronic hepatitis C type 1-infected cohort (pages

e144–e152)

D. Ramcharran, A. S. Wahed, H. S. Conjeevaram, R. W. , T. Wang, S. H. Belle

and L. J. Yee

Article first published online: 10 NOV 2010 | DOI:

10.1111/j.1365-2893.2010.01394.x

GB virus C infection among young, HIV-negative injection drug users with and

without hepatitis C virus infection (pages e153–e159)

B. Boodram, R. C. Hershow, D. Klinzman and J. T. Stapleton

Article first published online: 3 AUG 2010 | DOI:

10.1111/j.1365-2893.2010.01350.x

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...